CellChorus

CellChorus leverages artificial intelligence to analyze a vast number of microscopy videos concurrently, providing detailed insights into the movement, interaction, and performance of immune cells over time. This advanced analysis empowers clients to accelerate the discovery, development, manufacturing, and delivery of cell therapies, antibodies, vaccines, and other innovative treatments. By utilizing CellChorus's technology, organizations can achieve faster results, reduce expenses, and improve success rates in their therapeutic endeavors.

CellChorus serves a diverse clientele, including leading biopharmaceutical companies and emerging biotech startups focused on cell therapies, antibody therapeutics, and vaccines. Their clients include companies with approved CAR T-cell therapies, demonstrating the impact and value of CellChorus's solutions in the cutting-edge field of immunotherapy.